# Kjell Öberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kjell-oberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,236 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 97 |
| i10-index | 324 |
| Last Known Institution | Uppsala University Hospital |
| OpenAlex ID | https://openalex.org/A5107842538 |
| Works | 636 |

## Researcher papers

Showing 12 of 17.

- [Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors](https://scholariq.org/papers/phase-3-trial-of-sup-177-sup-lu-dotatate-for-midgut-neuroendocrine-tumors/)
- [Everolimus for Advanced Pancreatic Neuroendocrine Tumors](https://scholariq.org/papers/everolimus-for-advanced-pancreatic-neuroendocrine-tumors/)
- [Gastroenteropancreatic neuroendocrine tumours](https://scholariq.org/papers/gastroenteropancreatic-neuroendocrine-tumours/)
- [Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastroenteropancreatic-neuroendocrine-neoplasms-esmo-clinical-practice/)
- [Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/everolimus-plus-octreotide-long-acting-repeatable-for-the-treatment-of-advanced/)
- [ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site](https://scholariq.org/papers/enets-consensus-guidelines-update-for-the-management-of-distant-metastatic/)
- [ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary](https://scholariq.org/papers/enets-consensus-guidelines-for-the-management-of-patients-with-liver-and-other/)
- [Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids](https://scholariq.org/papers/pulmonary-neuroendocrine-carcinoid-tumors-european-neuroendocrine-tumor-society/)
- [Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-neuroendocrine-gastrointestinal/)
- [ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum](https://scholariq.org/papers/enets-consensus-guidelines-update-for-neuroendocrine-neoplasms-of-the-jejunum/)
- [Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With <sup>177</sup>Lu-Dotatate in the Phase III NETTER-1 Trial](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-progressive-midgut/)
- [Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome](https://scholariq.org/papers/telotristat-ethyl-a-tryptophan-hydroxylase-inhibitor-for-the-treatment-of/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Pituitary Gland Disorders and Treatments](https://scholariq.org/topics/pituitary-gland-disorders-and-treatments/)

## Researcher university

- [Uppsala University Hospital](https://scholariq.org/institutions/uppsala-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.